ANKRD22 is involved in the progression of prostate cancer

Prostate cancer is a common malignant tumor in elderly men. As a novel metabolic-reprogramming molecule, the role of ankyrin repeat domain 22 (ANKRD22) in the tumorigenesis and progression of prostate cancer remains unknown. In the present study, mouse monoclonal antibodies against human ANKRD22 wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Yiqing, Yang, Saisai, Pan, Tianhui, Yu, Lin, Liu, Jingwen, Zhu, Yongliang, Wang, Hongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732940/
https://www.ncbi.nlm.nih.gov/pubmed/31516611
http://dx.doi.org/10.3892/ol.2019.10738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732940/
https://www.ncbi.nlm.nih.gov/pubmed/31516611
http://dx.doi.org/10.3892/ol.2019.10738

Ejemplares similares